3 ms·
Beyond the things you point out, my biggest point of skepticism on Theranos is its business and the potential value of it. Lab Corp is worth $11 billion. With
by adventured 11y ago
Beyond the things you point out, my biggest point of skepticism on Theranos is its business and the potential value of it.
Lab Corp is worth $11 billion. With $6 billion in sales (and having generated ~$1.6 billion in profit over the last three years). The market Theranos is tackling is not as huge as some people apparently would like to think. Lab Corp is a monster in the field, and they're merely doing $11 billion. It's not an Uber situation, where a company blindsides an entire industry, and that industry stands still - Lab Corp has the resources and scale to respond to anything Theranos can do.
In the perfect scenario, Theranos is doing little more than pulling at least a decade of future returns forward at a $9 billion valuation. There's nothing they can do that will generate $6 billion in sales in the next five or six years. Their business model is partially built on neutering the high margins that companies like Lab Corp enjoy.
- dbcooper 11y agoAbaxis (manufacturers of the "Piccolo" systems, which seem to be lab-on-disc based and offer point-of-care operation) are an interesting company to compare to Theranos. They seem to be able to perform small panels of assays (up to 14) on 100 µL samples [1] obtained by venipuncture.[2] They are valued at $880M, and had ~ $200M revenue and $27M profit in the last financial year. http://www.abaxis.com/about_us/history.html http://www.abaxis.com/about_us/history.html [1] http://www.piccoloxpress.com/products/panels/function/ http://www.piccoloxpress.com/products/panels/function/ [2] http://www.piccoloxpress.com/wp-content/uploads/2015Revisions/400-7139-1RevP-ComprehensiveMetabolicReagentDisc.pdf http://www.piccoloxpress.com/wp-content/uploads/2015Revision...
- AndrewKemendo 11y agoThey are valued at $880M, and had ~ $200M revenue and $27M profit in the last financial year. If they were in startup world those numbers would probably make them over $1BN in valuation.
- pbreit 11y agoOnly if they are growing rapidly.
- pbreit 11y agoYou're thinking way too small. If it works, cheap at-home testing could change all of medicine.